Related Experiment Videos
delta-Globin gene structure and expression in the K562 cell line
Daniela Poddie1, Maria F Marongiu, Silvia Cigliuti Ferrari
1Istituto di Neurogenetica e Neurofarmacologia (INN), Consiglio Nazionale delle Ricerche (CNR), Selargius, Sardinia, Italy.
Hemoglobin
|December 3, 2003
Summary
The delta-globin gene is unexpectedly expressed in K562 cells, a finding crucial for understanding delta-thalassemia. This study reveals that transacting factors likely control this selective gene activation.
Area of Science:
- Molecular Biology
- Genetics
- Hematology
Background:
- The delta-globin gene produces Hb A2, normally <3% of hemoglobin.
- K562 cells exhibit embryonic-fetal globin expression, lacking adult beta-globin.
- Delta-globin gene activation is a potential therapy for delta-thalassemia.
Purpose of the Study:
- Investigate delta-globin gene activation in K562 cells.
- Determine nucleotide sequences of delta- and beta-globin genes.
- Analyze delta- and beta-globin mRNA levels and delta-globin gene expression.
Main Methods:
- Nucleotide sequencing of delta- and beta-globin genes.
- Reverse transcription-polymerase chain reaction (RT-PCR) for mRNA quantification.
- S1 mapping to assess endogenous delta-globin gene expression levels.
Main Results:
- No sequence variations found in delta- and beta-globin genes.
- Delta-globin mRNA constitutes >95% of total delta + beta-mRNA.
- Delta-globin gene expression is 12.3% relative to alpha-globin.
Conclusions:
- High delta-globin gene expression in K562 is likely due to the transacting environment.
- Specific transacting factors can selectively activate the human delta-globin gene.
- Identifying these factors is key to understanding gene activation mechanisms.